HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Adiphenine

HCID 2031
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
64-95-9
Standard SMILES
CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1
InChIKey
JGOAIQNSOGZNBX-UHFFFAOYSA-N
Molecular formula
C20H25NO2
Average molar mass
311.4 g/mol
Monoisotopic mass
311.18852904

Overview

2,2-diphenylacetic acid 2-(diethylamino)ethyl ester is a diarylmethane.

Names & identifiers

Preferred name
Adiphenine
IUPAC
2-(diethylamino)ethyl 2,2-diphenylacetate
English name
adiphenine
Molecular formula
C20H25NO2
Molecular weight
311.42

Names & synonyms

adiphenineAdipheninDiphacilTranzetilTrasentinDifacil64-95-9PatrovineSpasmolytinTransentineDiphacylVegantine
Show more names
TrasentineAcedoben Impurity 72-(diethylamino)ethyl diphenylacetateDiphenylacetic acid 2-(diethylamino)ethyl2-diethylaminoethyl 2,2-di(phenyl)acetate2-diethylaminoethyl 2,2-di(phenyl)ethanoate
AdifeninaTrazentynaWegantyna2-(diethylamino)ethyl 2,2-diphenylacetateAdipheninumDiphenylacetyldiethylaminoethanol2-Diethylaminoethyl diphenylacetateDiphenylacetic acid diethylaminoethyl ester

Database identifiers

CAS
64-95-9
PubChem CID
2031
DTXSID
DTXSID0022561
ChEMBL
CHEMBL353846
ChEBI
CHEBI:94680
UNII
YKG6OR043Q
EC Number
200-599-0
Nikkaji
J4.836D

Properties

Computed structural properties

XLogP
4.2
Topological polar surface area
29.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
3
Rotatable bonds
9
Heavy atoms
23
Formal charge
0
Complexity
311

Experimental & physicochemical properties

Human DrugsPharmaceuticals
DecompositionWhen heated to decomposition it emits toxic fumes of NOx.
Melting PointCrystals. MP: 113-114 °C; Readily soluble in water; very sparingly soluble in alcohol, ether /Hydrochloride/
Collision Cross Section175.23 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
113.5 °C · 113.5°C
Boiling point
451.46 °C · 451.46°C (rough estimate)
Density
1.0899 · 1.0899 (rough estimate)
refractive index
1.5614 · 1.5614 (estimate)
Water Solubility
18.36 mg/L · 18.36mg/L(37 ºC)
FDA UNII
6 OR043Q · YKG6OR043Q
Hazardous Substances Data
64 · 64-95-9(Hazardous Substances Data)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Other Safety InformationIMAP assessments - Benzeneacetic acid, .alpha.-phenyl-, 2-(diethylamino)ethyl ester: Environment tier I assessment

Safety & protection

Disposal Methods · 1 item

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxicology

Interactions · 2 items

ALTHOUGH THE DRUG IS RELATIVELY NONTOXIC, IT SHOULD NOT BE USED IN CLOSE SEQUENCE WITH MORPHINE; THE COMBINATION APPEARS TO CAUSE APPREHENSION & TACHYCARDIA. /ADIPHENINE HYDROCHLORIDE/

Spasmolytin (adiphenine hydrochloride) and tropicine were administered im to albino rats poisoned with anabasine sulfate doses of 346, 519, and 692 mg/kg administered through gastric tube. The LD50 of anabasine sulfate, determined for treatment with adiphenine hydrochloride, was 570 mg/kg, and 403 mg/kg for treatment with tropacine. The LD16 and LD84 values determined for treatment with adiphenine hydrochloride and tropacine were 460 and 712 mg/kg and 288 and 498 mg/kg, respectively. Adiphenine hydrochloride and tropacine, administered im in 20 mg/kg doses, reduced the LD50 of anabasine sulfate by 271% and 191%, respectively./Adiphenine hydrochloride/

Non-Human Toxicity Excerpts · 1 item

/ALTERNATIVE and IN VITRO TESTS/The mechanism of action of adiphenine on in vitro rat anterior pituitary TSH release was compared to that of the physiological stimulator TRH. The comparative study showed that adiphenine and TRH were able to increase TSH release in a dose-dependent manner, had similar time courses of action for equipotent stimulating concentrations and produced similar aspects of stimulated TSH cells. However, there were several differences between the effects of adiphenine and TRH. Adiphenine action was inhibited by 20 mM K+; was not calcium dependent; was inhibited by neither thyroid hormones nor somatostatin; was little affected by energy depression. It is concluded that adiphenine probably acts near the ultimate steps of the TSH release pathway and could be a useful pharmacological tool for studying the mechanism of TSH release.

Chemistry & industry

Pharmacology

Biological Half-Life · 1 item

Adiphenine was administered in 3H-labelled form in doses of 15 mumole/kg intravenously to male Wistar rats. Plasma and brain levels of the unchanged drug were measured. The elimination of the 3H-labelled compound from the plasma was monophasic with a half-life of 13 minutes. The unchanged drug was detectable in the plasma for 30 minutes after the injection. The time course of brain levels of unchanged drug paralleled that found in the plasma with a half-life of 9 to 12 minutes. In all experiments, brain and plasma levels of unchanged adiphenine correlate highly.

Metabolism/Metabolites · 2 items

Major metabolites isolated from rat urine after administration of a single dose of (14C)adiphenine or (3H)adiphenine were identified by chromatography and n.m.r. spectrometry, and by comparison with authentic reference compounds chemically synthesized. Adiphenine was extensively metabolized by hydrolysis of the ester bond into diethylaminoethanol, diphenylacetic acid, diphenylacetic acid glucuronide and, in small quantities, the corresponding glycine and glutamine conjugates.

The disposition of adiphenine labelled with 14C in two positions has been investigated in rats and mice after iv administration ... In preliminary metabolic studies, three major metabolites have been identified: diphenylacetic acid, diethylethanolamine and a diphenylacetic acid glucuronide.

Absorption, Distribution and Excretion · 2 items

This study describes the behavior of a dual labelled drug, adiphenine, in the rat brain. Macroautoradiographies show images of the brain at different times after injection. Some of the tissue metabolites are identified at the brain level and the passage of the blood brain barrier is compared with tritiated water. The obtained data give very interesting indications on the blood brain distribution and on the metabolism at the brain level. Different techniques of high pressure liquid chromatography, macro- and histoautoradiographies allowed /visualization of/ how the drug is fixed on cerebral structures, giving indications on its mechanism of action.

The disposition of adiphenine labelled with 14C in two positions has been investigated in rats and mice after iv administration, and has been compared with that of the [14C]diethylethanolamine HCl and of the [14C]diphenylacetic acid. Radioactivity in the blood declined in a biphasic manner. Biliary elimination depended upon the 14C-labelled compound administered: less than 5% dose for the diethylethanolamine moiety, 100% dose for the carboxylic moiety. Of the radioactivity appearing in rat bile, less than 1% is associated with unchanged adiphenine. ... Uptake by the brain of [14C]adiphenine shortly after dosing is 15 times greater than that of blood. Radioactivity is also found in the hypophysis, the adrenals and melanoid pigments, with a concentration up to 30 times greater than that found in the blood.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Antidote and Emergency Treatment · 3 items

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

Non-Human Toxicity Values · 5 items

LD50 rat intravenous 27 mg/kg

LD50 mouse oral 600 mg/kg

LD50 mouse subcutaneous 400 mg/kg

LD50 mouse intravenous 21.5 mg/kg

For more Non-Human Toxicity Values (Complete) data for ADIPHENINE (6 total), please visit the HSDB record page.

Safety data

Hazardous Substances Data
64-95-9(Hazardous Substances Data)

Uses & manufacturing

Uses · 3 items

THERAP CAT: Antispasmodic

MEDICATION

MEDICATION (VET)

Methods of Manufacturing · 2 items

PREPD BY ACTION OF DIPHENYLACETYL CHLORIDE OR DIPHENYL KETENE ON DIETHYLAMINOETHANOL: SWISS PATENT 190,541 (1937 TO CIBA); GER PATENTS 626,539; 653,778 (1937). /ADIPHENINE HYDROCHLORIDE/

Preparation: DE 626539 (1936 to Ciba)

Use ClassificationPharmaceuticals
General Manufacturing InformationAntiacid for relief of gastric hyperacidity /Carmethose-Trasentine/ /Former/

Applications

UsesRelaxant (smooth muscle).

Upstream & downstream products

Upstream raw materials

DiethylaminoethanolThionyl chloride

Additional notes

DefinitionChEBI: 2,2-diphenylacetic acid 2-(diethylamino)ethyl ester is a diarylmethane.